Preparing for PrEP: Perceptions and readiness of Canadian physicians for the implementation of HIV pre-exposure prophylaxis

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Sharma, Malika ^a   Wilton, James ^b   Senn, Heather ^a   Fowler, Shawn ^c   Tan, Darrell H S ^a,c,d  

^a UNIVERSITY OF TORONTO   (Canada)

^b Canadian AIDS Treatment Information Exchange ^*  (Canada)

^c Hassle Free Clinic   (Canada)

^d ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AWARENESS; CANADA; COMMUNITY CARE; HEALTH CARE PLANNING; HEALTH CARE PRACTICE; HUMAN; KNOWLEDGE; MEDICAL EDUCATION; PERCEPTION; PRE EXPOSURE PROPHYLAXIS; PREVENTIVE MEDICINE; PROPHYLAXIS; ATTITUDE TO HEALTH; FEMALE; HIV INFECTIONS; MALE; PHYSICIAN; PRE-EXPOSURE PROPHYLAXIS; PSYCHOLOGY;

CANADA; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HIV INFECTIONS; HUMANS; MALE; PHYSICIANS; PRE-EXPOSURE PROPHYLAXIS;

EID: 84925515039     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0105283     Document Type: Article

References (38)

1. Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, et al. (2010) Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med 363: 2587-2599.
2. Baeten JM, Donnell D, Ndase P, Mugo NR, Campbell JD, et al. (2012) Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med 367: 399-410.
3. Thigpen MC, Kebaabetswe PM, Paxton LA, Smith DK, Rose CE, et al. (2012) Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in botswana. N Engl J Med 367: 423-434.
4. Choopanya K, Martin M, Suntharasamai P, Sangkum U, Mock PA, et al. (2013) Antiretroviral prophylaxis for HIV infection in injecting drug users in bangkok, thailand (the bangkok tenofovir study): A randomised, double-blind, placebo-controlled phase 3 trial. Lancet 381: 2083-2090.
5. Van Damme L, Corneli A, Ahmed K, Agot K, Lombaard J, et al. (2012) Preexposure prophylaxis for HIV infection among african women. N Engl J Med 367: 411-422.
6. van der Straten A, Van Damme L, Haberer JE, Bangsberg DR (2012) Unraveling the divergent results of pre-exposure prophylaxis trials for HIV prevention. AIDS 26: F13-9.
7. Marrazzo J, Ramjee G, Nair G, Palanee T, Mkhize B, et al. (2013) 〈br/〉 Preexposure prophylaxis for HIV in women: Daily oral tenofovir, oral tenofovir/ emtricitabine, or vaginal tenofovir gel in the VOICE study (MTN 003). 20th Conference on Retroviruses and Opportunistic Infections Abstract 26LB.
8. Hurt CB, Eron JJ Jr, Cohen MS (2011) Pre-exposure prophylaxis and antiretroviral resistance: HIV prevention at a cost? Clin Infect Dis 53: 1265-1270.
9. Supervie V, Garcia-Lerma JG, Heneine W, Blower S (2010) HIV, transmitted drug resistance, and the paradox of preexposure prophylaxis. Proc Natl Acad Sci U S A 107: 12381-12386.
10. Golub SA, Kowalczyk W, Weinberger CL, Parsons JT (2010) Preexposure prophylaxis and predicted condom use among high-risk men who have sex with men. J Acquir Immune Defic Syndr 54: 548-555.
11. Guest G, Shattuck D, Johnson L, Akumatey B, Clarke EE, et al. (2008) Changes in sexual risk behavior among participants in a PrEP HIV prevention trial. Sex Transm Dis 35: 1002-1008.
12. Walensky RP, Park JE, Wood R, Freedberg KA, Scott CA, et al. (2012) The cost-effectiveness of pre-exposure prophylaxis for HIV infection in south african women. Clin Infect Dis 54: 1504-1513.
13. Koppenhaver RT, Sorensen SW, Farnham PG, Sansom SL (2011) The cost-effectiveness of pre-exposure prophylaxis in men who have sex with men in the united states: An epidemic model. J Acquir Immune Defic Syndr 58: e51-2.
14. Eisingerich AB, Wheelock A, Gomez GB, Garnett GP, Dybul MR, et al. (2012) Attitudes and acceptance of oral and parenteral HIV preexposure prophylaxis among potential user groups: A multinational study. PLoS One 7: e28238.
15. Mimiaga MJ, Case P, Johnson CV, Safren SA, Mayer KH (2009) Preexposure antiretroviral prophylaxis attitudes in high-risk boston area men who report having sex with men: Limited knowledge and experience but potential for increased utilization after education. J Acquir Immune Defic Syndr 50: 77-83.
16. Barash EA, Golden M (2010) Awareness and use of HIV pre-exposure prophylaxis among attendees of a seattle gay pride event and sexually transmitted disease clinic. AIDS Patient Care STDS 24: 689-691.
17. Liu AY, Kittredge PV, Vittinghoff E, Raymond HF, Ahrens K, et al. (2008) Limited knowledge and use of HIV post- and pre-exposure prophylaxis among gay and bisexual men. J Acquir Immune Defic Syndr 47: 241-247. (Pubitemid 351172193)
18. Leonardi M, Lee E, Tan DH (2011) Awareness of, usage of and willingness to use HIV pre-exposure prophylaxis among men in downtown toronto, canada. Int J STD AIDS 22: 738-741.
19. Centers for Disease Control and Prevention (CDC) (2011) Interim guidance: Preexposure prophylaxis for the prevention of HIV infection in men who have sex with men. MMWR Morb Mortal Wkly Rep 60: 65-68.
20. Centers for Disease Control and Prevention (CDC) (2012) Interim guidance for clinicians considering the use of preexposure prophylaxis for the prevention of HIV infection in heterosexually active adults. MMWR Morb Mortal Wkly Rep 61: 586-589.
21. Ministere de la Sante et des Services sociaux (July 10, 2013) Avis intérimaire sur la prophylaxie preexposition au virus de l'immunodeficience humaine. 2013.
22. Underhill K, Operario D, Skeer M, Mimiaga M, Mayer K (2010) Packaging PrEP to prevent HIV: An integrated framework to plan for pre-exposure prophylaxis implementation in clinical practice. J Acquir Immune Defic Syndr 55: 8-13.
23. Arnold EA, Hazelton P, Lane T, Christopoulos KA, Galindo GR, et al. (2012) A qualitative study of provider thoughts on implementing pre-exposure prophylaxis (PrEP) in clinical settings to prevent HIV infection. PLoS One 7: e40603.
24. White JM, Mimiaga MJ, Krakower DS, Mayer KH (2012) Evolution of massachusetts physician attitudes, knowledge, and experience regarding the use of antiretrovirals for HIV prevention. AIDS Patient Care STDS 26: 395-405.
25. Tripathi A, Ogbuanu C, Monger M, Gibson JJ, Duffus WA (2012) Preexposure prophylaxis for HIV infection: Healthcare providers' knowledge, perception, and willingness to adopt future implementation in the southern US. South Med J 105: 199-206.
26. Puro V, Palummieri A, De Carli G, Piselli P, Ippolito G (2013) Attitude towards antiretroviral pre-exposure prophylaxis (PrEP) prescription among HIV specialists. BMC Infect Dis 13: 217-2334-13-217.
27. Karris MY, Beekmann SE, Mehta SR, Anderson CM, Polgreen PM (2013) Are we prepped for PrEP? provider opinions on the real-world use of PrEP in the U.S. and canada. Clin Infect Dis doi:10.1093/cid/cit796.
28. Krakower D, Mayer KH (2012) What primary care providers need to know about preexposure prophylaxis for HIV prevention: A narrative review. Ann Intern Med 157: 490-497.
29. Tellalian D, Maznavi K, Bredeek UF, Hardy WD (2013) Pre-exposure prophylaxis (PrEP) for HIV infection: Results of a survey of HIV healthcare providers evaluating their knowledge, attitudes, and prescribing practices. AIDS Patient Care STDS 27: 553-559.
30. Feinberg J (2012) Truvada PrEP: Why I voted "yes". Ann Intern Med 157: 521-522.
31. Wood LV (2012) Why I voted "no" to truvada PrEP. Ann Intern Med 157: 519-520.
32. Baeten JM, Haberer JE, Liu AY, Sista N (2013) Preexposure prophylaxis for HIV prevention: Where have we been and where are we going? J Acquir Immune Defic Syndr 63 Suppl 2: S122-9.
33. Cohen SE, Vittinghoff E, Anderson P, Doblecki-Lewis S, Bacon O, et al. (2014) Implementation of PrEP in STD clinics: High uptake and drug detection among MSM in the demonstration project [abstract 954]. Top Antivir Med 22(e-1): 500.
34. Mayer KH, Oldenberg C, Novak D, Krakower D, Mimiaga M (2014) Early adopters: Correlates of chemoprophylaxis use in an online sample of US men who have sex with men. [abstract 952]. Top Antivir Med 22(e-1): 499.
35. Senn H, Wilton J, Sharma M, Fowler S, Tan DH (2013) Knowledge of and opinions on HIV preexposure prophylaxis among front-line service providers at canadian AIDS service organizations. AIDS Res Hum Retroviruses 29: 1183-1189.
36. Yoong DM, Naccarato M, Sharma M, Wilton J, Senn H, et al. (2013) Preparing for PrEP: Assessing perceptions, beliefs, and readiness of canadian pharmacists for the implementation of HIV pre-exposure prophylaxis. Canadian Association for HIV Research Abstract P096.
37. Liu A, Stojanovski K, Lester R, Amico KR, et al. (2013) Developing and implementing a mobile health (mHealth) adherence support system for HIV-uninfected men who have sex with men (MSM) taking pre-exposure prophylaxis (PrEP): The iText study. 8th international Conference on HIV Treatment and Prevention Abstract OA165.
38. Anderson PL, Glidden DV, Liu A, Buchbinder S, Lama JR, et al. (2012) Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men. Sci Transl Med 4: 151ra125.